Summit Therapeutics (SMMT) shares jumped roughly 25% in premarket trade Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in the clinical-stage oncology company and…
Marvell Technology (NASDAQ: MRVL) is likely to raise its fiscal 2029 AI revenue forecast by at least $2 billion, according to RBC Capital Markets. In…
MongoDB Shares Sink 18% as CEO Chirantan Desai Exits for Meta
MongoDB (NASDAQ: MDB) lost its chief executive on Monday. Chirantan Desai is leaving after less than a year in the job to become chief enterprise…
Microsoft Corporation Launches Autopilot and Makes User Trust the Center of Its Enterprise AI Push
Microsoft Corporation (NASDAQ: MSFT) on Friday launched Autopilot, a new version of its Copilot platform that puts chat, coding and agentic AI into one enterprise…
Satellos Bioscience Clears FDA Hurdle for Second Indication — and Funds It Without Dilution
Satellos Bioscience (MSLE) announced Thursday that the US Food and Drug Administration cleared its Investigational New Drug application for forazapadin in facioscapulohumeral muscular dystrophy, opening…
Beneficient (NASDAQ: BENF) shares jumped 438.73% on Wednesday to close at $2.90. The rally came after the alternative-asset liquidity provider announced a plan to cut…
Boeing Scales Back China Hopes as Trump-Xi Summit Arrives
Boeing Company (NYSE: BA) is heading into Thursday’s summit between President Donald Trump and Chinese President Xi Jinping with lower expectations. Rather than chasing a…
KB Home (KBH) beat Wall Street on third-quarter earnings and the stock fell anyway. The homebuilder cut its full-year housing gross margin guidance late Tuesday,…
McDonald’s (MCD) used its first investor day in nearly three years to unveil “NEXT,” a strategy built to reverse sliding US traffic and restore franchisee…
USA Rare Earth Takes Center Stage in America’s Rare Earth Push as Trump–Xi Summit Nears
USA Rare Earth (Nasdaq: USAR) has become one of the clearest ways for investors to bet on Washington’s plan to break China’s hold on rare…
Viking Therapeutics Shares Jump 36% After New Obesity Data Shows Patients Keep the Weight Off
Viking Therapeutics (Nasdaq: VKTX) shares rose 35.7% to close at $40.85 on Tuesday. The rally followed new clinical data for VK2735, the company’s experimental weekly…
Novo Nordisk (NVO) laid out its long-term growth ambitions at a capital markets day in London on Monday, and shareholders responded by marking the stock…





